Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

YLT192

SKU: orb1702925

Description

YLT192 is an orally bioavailable small molecule inhibitor targeting VEGFR2, demonstrating potent antiangiogenic and antitumor activity. It is utilized in cancer research, showing efficacy in both in vitro assays and in vivo tumor models for studying angiogenesis and tumor growth inhibition.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

CAS Number1246566-47-1
MW377.39
FormulaC21H19N3O4
SMILESO(C=1C=C(C(NC)=O)N=CC1)C2=CC=C(NC(=O)C3=CC(OC)=CC=C3)C=C2
TargetOthers,VEGFR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information